| ASSET | QUARTER | % RETURN |
|---|---|---|
Beeline (BLNE) | Q3 2015 | 14,541.14% |
VerifyMe (VRME) | Q3 2015 | 4,905.38% |
MDxHealth (MDXH) | Q3 2015 | 760% |
GreenPro Capital (GRNQ) | Q3 2015 | 614.29% |
Akari Therapeutics (AKTX) | Q3 2015 | 299.92% |
Anavex Life Sciences (AVXL) | Q3 2015 | 208.2% |
Aytu BioScience (AYTU) | Q3 2015 | 174.12% |
authID (AUID) | Q3 2015 | 150% |
Workhorse (WKHS) | Q3 2015 | 139.95% |
ProMIS Neurosciences (PMN) | Q3 2015 | 133.33% |
CEA Industries (BNC) | Q3 2015 | 121.82% |
Nixxy (NIXX) | Q3 2015 | 110% |
Nexentis Technologies (NXTS) | Q3 2015 | 100% |
Neurogene (NGNE) | Q3 2015 | 99.57% |
Forward Industries (FWDI) | Q3 2015 | 99.26% |
Rocket Pharmaceuticals (RCKT) | Q3 2015 | 88.76% |
Can Fite Biopharma Ltd ADR (CANF) | Q3 2015 | 86.32% |
CleanSpark (CLSK) | Q3 2015 | 84.21% |
JX Luxventure (JXG) | Q3 2015 | 78.04% |
EDAP TMS (FOCL) | Q3 2015 | 71.47% |
Educational Development (EDUC) | Q3 2015 | 63.8% |
FiEE (FIEE) | Q3 2015 | 62.24% |
Lifevantage (LFVN) | Q3 2015 | 62% |
Xenetic Biosciences (XBIO) | Q3 2015 | 61.36% |
Exelixis (EXEL) | Q3 2015 | 55.83% |